Key result
Clinical evaluation of 100 patients with genetically proven Fabry disease revealed that classic textbook signs are misleading, with only 1 patient exhibiting a restrictive cardiac pattern.
Cohort (n=100)
Traditional terms used to describe Fabry disease symptoms (angiokeratoma, acroparaesthesia, restrictive cardiomyopathy) may be misleading and should be updated to reflect actual clinical presentations.
Answers are grounded in this paper and cite their sources.
Restrictive cardiomyopathy appears rare in genetically confirmed Fabry disease; challenges classic teaching and leaves open prospective validation of phenotypes.
BACKGROUND: Signs and symptoms of classic Fabry disease manifest itself on the skin (angiokeratoma), the nervous system (acroparaesthesia), the heart (restrictive cardiomyopathy) and a variety of other organs. MATERIALS AND METHODS: Diagnosis of Fabry disease was confirmed by genetic tests in a cohort of 100 patients and a standardized examination programme was performed in all patients. We were puzzled when applying well-established and textbook-anchored signs and symptoms to our patients. RESULTS: Among the 47 male and 53 female patients (mean age 41 +/- 16 years) with genetically proven disease, the Fabry-type vascular skin lesions were without hyperkeratotic aspect and keratomas were virtually absent. The peripheral neuropathic pain found in all male patients was not compatible with the wording 'acro' and 'paraesthesia', suggesting a different pathophysiological mechanism. Upon echocardiographic examination, patients mainly revealed diastolic relaxation abnormalities of the heart and only one patient had a restrictive cardiac pattern. CONCLUSIONS: Our findings suggest that some terms used to describe signs and symptoms of Fabry disease are historically derived and do not comply with state-of-the-art examination. We propose to replace the term 'angiokeratoma' with 'angioma', the term 'acroparaesthesia' with 'neuropathic pain' and the term 'restrictive cardiomyopathy' with 'cardiac hypertrophic storage disease'. As most of the physicians are not familiar with Fabry disease, terms used in the past might prevent the correct diagnosis of a potentially treatable disease.
No takes yet. Share an insight, caveat, or question.
Weidemann et al. (2008) conducted a cohort in Fabry disease (n=100). Clinical evaluation of signs and symptoms was evaluated on Presence of classic Fabry disease signs and symptoms. Clinical evaluation of 100 patients with genetically proven Fabry disease revealed that classic textbook signs are misleading, with only 1 patient exhibiting a restrictive cardiac pattern.
Synapse has enriched 10 related papers. Consider them for comparative context: